John M Morin

US Patent:

6376492, Apr 23, 2002

Filed:

May 9, 2000

Appl. No.:

09/567857

Inventors:

Peter Thomas Lind - Huddinge, SE
Rolf Noréen - Huddinge, SE
John Michael Morin - Brownsburg IN
Robert John Ternansky - Carlsbad CA

Assignee:

Medivir AB - Huddinge

International Classification:

A61K 31252

US Classification:

514252, 514255, 514256, 544238, 544241, 544297, 544322, 544333, 544359, 544392, 544403

Abstract:

The present invention is directed to compounds, compositions and methods of inhibiting and treating HIV and related viruses, and methods for cocrystallizing reverse transcriptase in vitro, inhibition of the replication of HIV and related viruses thereof.

US Patent:

6713505, Mar 30, 2004

Filed:

Dec 3, 2002

Appl. No.:

10/297282

Inventors:

Michael Dean Kinnick - Indianapolis IN
Ho-Shen Lin - Indianapolis IN
Michael John Martinelli - Zionsville IN
John Michael Morin - Brownsburg IN
Michael Enrico Richett - Indianapolis IN

Assignee:

Eli Lilly and Company - Indianapolis IN

International Classification:

A61K 3138

US Classification:

514443, 549 51

Abstract:

A class of novel benzo(b)thiophene is disclosed together with the use of such compounds for inhibiting sPLA mediated release of fatty acids for treatment of Inflammatory Diseases such as septic shock.

US Patent:

6930123, Aug 16, 2005

Filed:

Dec 6, 2001

Appl. No.:

10/450929

Inventors:

Douglas Wade Beight - Frankfort IN, US
Michael Dean Kinnick - Indianapolis IN, US
Ho-Shen Lin - Indianapolis IN, US
John Michael Morin - Brownsburg IN, US
Michael Enrico Richett - Indianapolis IN, US
Daniel Jon Sall - Greenwood IN, US
Jason Scott Sawyer - Indianapolis IN, US
Edward C R Smith - Fishers IN, US

Assignee:

Eli Lilly and Company - Indianapolis IN

International Classification:

A61K031/40
C07D209/56
A61P029/00

US Classification:

514411, 548427

Abstract:

A novel class of benz[f]indole compounds is disclosed together with the use of such compounds for inhibiting sPLAmediated release of fatty acids for treatment of Inflammatory Diseases such as septic shock.

US Patent:

6974831, Dec 13, 2005

Filed:

Dec 6, 2001

Appl. No.:

10/450741

Inventors:

Douglas Wade Beight - Frankfort IN, US
Michael Dean Kinnick - Indianapolis IN, US
Ho-Shen Lin - Indianapolis IN, US
John Michael Morin - Brownsburg IN, US
Michael Enrico Richett - Indianapolis IN, US
Daniel Jon Sall - Greenwood IN, US
Jason Scott Sawyer - Indianapolis IN, US
Edward C R Smith - Fishers IN, US

Assignee:

Eli Lilly and Company - Indianapolis IN

International Classification:

A61K031/404
C07D209/56

US Classification:

514411, 548427

Abstract:

A novel class of cycloalkyl fused indole compounds is disclosed together with the use of such compounds for inhibiting sPLA2 mediated release of fatty acids for treatment of Inflammatory Diseases such as septic shock.

US Patent:

7132456, Nov 7, 2006

Filed:

Dec 3, 2003

Appl. No.:

10/536053

Inventors:

James Ronald Gillig - Indianapolis IN, US
Lawrence Joseph Heinz - Pittsboro IN, US
Michael Dean Kinnick - Indianapolis IN, US
John Michael Morin - Brownsburg IN, US
Nancy June Snyder - Lizton IN, US

Assignee:

Eli Lilly and Company - Indianapolis IN

International Classification:

A61K 31/165
C07C 55/06
C07C 323/42

US Classification:

514618, 562597, 564162

Abstract:

The present invention relates to a melanin concentrating hormone antagonist compound of Formula I: (I) wherein Ar, Ar, Ar, L, Land Q areas defined, or a pharmaceutically acceptable salt, solvate, enantiomer or mixture of diastereomers thereof useful in the treatment, prevention or amelioration of symptoms associated with obesity and Related Diseases.

US Patent:

7160909, Jan 9, 2007

Filed:

Jul 29, 2002

Appl. No.:

10/484015

Inventors:

Michael Dean Kinnick - Indianapolis IN, US
Edward David Mihelich - Carmel IN, US
John Michael Morin - Brownsburg IN, US
Daniel Jon Sall - Greenwood IN, US
Jason Scott Sawyer - Indianapolis IN, US

Assignee:

Eli Lilly and Company - Indianapolis IN

International Classification:

A61K 31/403
A61K 31/433
C07D 209/56
C07D 285/10

US Classification:

514362, 548134, 548135, 548427, 548439, 548448, 514411

Abstract:

A novel class of tricyclic compounds of the following formula (I) is disclosed together with the use of such compounds for inhibiting sPLAmediated release of fatty acids for treatment of Inflammatory Diseases such as septic shock.

US Patent:

8025591, Sep 27, 2011

Filed:

Dec 19, 2008

Appl. No.:

12/339326

Inventors:

Noah De La Cruz - Carlsbad CA, US
Charles E. Golden - Carlsbad CA, US
John W. Morin - Carlsbad CA, US

Assignee:

Acushnet Company - Fairhaven MA

International Classification:

A63B 53/04

US Classification:

473344, 473345, 473349

Abstract:

A golf club is provided having a hollow body golf club head comprising discrete concentrations of weight or mass located away from the center of gravity or the geometric center of the club head to optimize the moment of inertia of the club head about both the vertical axis running through the center of gravity or geometric center of the club head, hereinafter referred to as the “y-axis,” and the axis running through the center of the shaft of the golf club, hereinafter referred to as the “hosel axis. ” The ratio of moment of inertia of the club head about the y-axis to moment of inertia of the club head about the hosel axis is preferably 0. 55. More preferably, this ratio is 0. 75.

US Patent:

8187120, May 29, 2012

Filed:

May 29, 2009

Appl. No.:

12/474316

Inventors:

Peter J. Gilbert - Carlsbad CA, US
Charles E. Golden - Carlsbad CA, US
Scott A. Knutson - Carlsbad CA, US
John Morin - Carlsbad CA, US

Assignee:

Acushnet Company - Fairhaven MA

International Classification:

A63B 53/04

US Classification:

473350

Abstract:

A wedge type golf club head is disclosed herein where the wedge type golf club head has enhanced performance characteristics such as improved backspin, ball speed, and launch angle. More specifically, the present invention relates to a wedge type golf club head having a lower center of gravity, where the center of gravity is located substantially behind the hitting surface and substantially along a neutral axis behind the point of impact.